BECTON, DICKINSON AND COMPANY Proceeds from Issuance or Sale of Equity
BECTON, DICKINSON AND COMPANY (BDX) reported Proceeds from Issuance or Sale of Equity of $0 for the 12-month period ending 2022-09-30, per its 10-K filed 2022-11-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2022-11-22
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for the quarter ending 2021-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for the quarter ending 2020-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for the quarter ending 2019-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for fiscal 2022 was $0.00.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for fiscal 2020 was $2.92B.
- BECTON, DICKINSON AND COMPANY proceeds from issuance or sale of equity for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 10-K · filed 2022-11-22 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $0.00 10-K · filed 2022-11-22 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | ||||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $2.92B 10-K · filed 2022-11-22 | |||
| 2020-06-30 | $2.92B 10-Q · filed 2021-08-05 | ||||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $0.00 10-K · filed 2021-11-24 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | ||||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $0.00 10-K · filed 2020-11-25 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | ||||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $4.80B derived: sum of 2 quarters · filed 2019-11-27 | $4.83B 10-K · filed 2019-11-27 | ||
| 2017-06-30 | $4.80B 10-K · filed 2019-11-27 | $4.83B 10-Q · filed 2018-08-02 | |||
| 2017-05-31 | $4.80B 10-K · filed 2019-11-27 | ||||
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | $0.00 10-K · filed 2018-11-21 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | ||||
| 2015-09-30 | $0.00 10-K · filed 2017-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |